Helping to Place the Pieces Together Through Leadership ... - NHIA

FIAC Profile
Moog Medical Devices
Moog is a worldwide designer, manufacturer, and integrator
of precision control components and systems. Since
1951, it has developed and provided the critical components
necessary for aircraft navigation safety and helped to enable
space vehicles to explore the universe. Moog’s systems control
military and commercial aircraft, satellites and space vehicles,
launch vehicles, missiles, automated industrial machinery, and marine
applications. Careful attention to precision and detail is priority
in everything Moog does, from aerospace and defense to the acquisition
and development of infusion and enteral therapy devices.
Moog’s expertise brings the medical market advanced technologies for the precision control of motion and fluids. Delivering
the precise, reliable control of fluid movement, simplifying processes, increasing safety and enhancing patient and
caregiver outcomes is a strength that Moog has applied to a range of medical pump technologies.
Through research and development, and the expertise of its people, Moog develops advanced infusion systems that improve
medication safety, optimize application performance, and reduce medical expenses. Moog strives to simplify the
programming and delivery of correct therapy dosages while enabling improved patient health and mobility. Our infusion
and enteral products are used in both the inpatient and alternate­site infusion therapy settings.
Products and Innovation
Between 2006 and 2007, Moog acquired Curlin Medical and Zevex International, two infusion pump manufacturers already
established in the home and alternate­site infusion industry. These companies possessed expertise in clinical engineering,
sales, and distribution. Combining the capabilities inherited from these organizations with
Moog’s own resources enhanced existing products and services and brought about
exciting new advancements in infusion therapy products.
The unique PainSmart ® IOD (Information on Demand) and 4000/6000 Clinical
Management System at­home infusion and ambulatory infusion pumps address the
need for precise, controlled delivery of infusion therapy drugs. Because they prohibit
users from bypassing drug libraries and establishing default rate settings for
certain drugs, these pumps ensure the correct therapeutic medications are administered
at the correct dosages. The development of truly smart pumps has addressed
providers’ needs to deliver medications to patients at controlled rates and
to adjust dosages as needed.
In 1996, Zevex entered the enteral feeding market with the EnteraLite ® ambulatory
enteral feeding pump. This product was the result of an extensive research effort
that included soliciting customer input during the initial ideation stage as well as during product
design and development. The result was a pump that offered accuracy and virtually unlimited mobility. In 2005, Zevex built
on the achievement by launching its successor, the EnteraLite ® Infinity, a smaller, more rugged and easier­to­use device.
With the purchase of Zevex, Moog was able to expand its reach into the ambulatory enteral feeding market. Further research
led to the development of the Infinity Orange ® , an enteral­only feeding system that provides highly accurate small­volume
feedings. The Infinity Orange ® improves patient safety by reducing programming errors and eliminating the possibility of misconnections.
These devices provide neonatal and pediatric populations precise and reliable enteral feeding options.
16